Risk factors related to the recurrence of pneumothorax in patients with emphysema.

J Thorac Dis

Department of Thoracic and Cardiovascular Surgery, Wonju College of Medicine, Yonsei University, Wonju-si, Gangwon-do, Republic of Korea.

Published: October 2020

AI Article Synopsis

  • Pneumothorax is the presence of air in the thoracic cavity, often seen in smokers, and its diagnosis is commonly aided by CT scans, which also identify pulmonary emphysema (PE).
  • A study analyzed 164 patients who had their first spontaneous pneumothorax, discovering that 30.6% experienced recurrence, with the median time to recurrence being 12.4 months post-treatment.
  • Findings indicated that lower forced expiratory volume (FEV) after recovery was significantly linked to a higher risk of pneumothorax recurrence, suggesting pulmonary function tests may be helpful in predicting this outcome.

Article Abstract

Background: Pneumothorax refers to the abnormal presence of air in the thoracic cavity. Pulmonary emphysema (PE) is often detected during computed tomography (CT), one of the radiological investigations used to diagnose pneumothorax and devise treatment plans in former or current smokers who present with pneumothorax. However, there are few reports that describe the recurrence rate and risk factors associated with recurrence in patients with PE and pneumothorax.

Methods: This study retrospectively cross-sectional analyzed the medical records of 164 patients diagnosed with their first episode of secondary spontaneous pneumothorax and admitted to a tertiary care hospital, between March 2013 and February 2019. The CT scans of 98 patients revealed PE, and 49 patients of those underwent pulmonary function tests (PFTs) after the resolution of pneumothorax. Risk factors for recurrence were analyzed using Cox proportional hazard regression.

Results: All the subjects were male and former or current smokers, with a median age of 72 years. Thirty-seven (75.5%) patients were treated with tube thoracostomy alone, whereas 12 (24.5%) patients underwent chemical pleurodesis via chest tube or video-assisted thoracoscopic surgery. After recovery from pneumothorax, these patients underwent PFT within a median time period of 5.8 months. Median forced vital capacity and forced expiratory volume in 1 second (FEV) were 3.02 L (91% predicted) and 1.58 L (67% predicted), respectively. In the current study, the recurrence rate of pneumothorax was observed to be 30.6%, within a median time period of 12.4 months. In multivariable-adjusted analysis, decreased FEV was observed to be significantly higher in the patients who exhibited recurrence of pneumothorax than in those who did not (adjusted hazard ratio, 0.408; P=0.025).

Conclusions: In patients with PE and pneumothorax, PFT, performed after recovery, could be a useful test for predicting the recurrence of pneumothorax.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656424PMC
http://dx.doi.org/10.21037/jtd-20-1557BDOI Listing

Publication Analysis

Top Keywords

risk factors
12
recurrence pneumothorax
12
patients underwent
12
pneumothorax
11
patients
10
factors recurrence
8
pneumothorax patients
8
current smokers
8
recurrence rate
8
median time
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!